Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CAPR	CAPRICOR THERAPEUTICS INC	$256.02M	-71.00%	-56.10%	-83.42%	-78.10%	0.51	3.59	100.00%	-736.60%	-736.62%
ANNX	ANNEXON INC	$324.20M	-93.10%	-72.90%	-111.57%	-120.40%	0.42	4.43	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$69.74M	N/A	-199.10%	476.73%	-544.00%	-1.60	0.67	70.80%	-2,885.80%	-2,881.12%
AMIX	AUTONOMIX MEDICAL INC	$5.01M	-213.40%	-172.60%	-257.56%	1,440.30%	0.23	5.31	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$364.62M	-63.80%	-30.90%	-40.97%	-28.80%	1.49	6.19	-61.20%	-439.70%	-463.91%
MNMD	MIND MEDICINE (MINDMED) INC	$1.12B	-86.20%	-62.30%	-95.18%	-120.30%	0.81	3.30	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$705.21M	-82.80%	-61.60%	-89.68%	-75.20%	0.48	6.31	N/A	N/A	N/A
VKTX	VIKING THERAPEUTICS INC	$4.42B	-29.30%	-28.40%	-33.28%	-31.20%	0.04	28.34	N/A	N/A	N/A
WHWK	WHITEHAWK THERAPEUTICS INC	$100.85M	-10.40%	-9.60%	-9.94%	-37.60%	0.06	16.76	89.20%	-108.60%	-108.58%
NVCT	NUVECTIS PHARMA INC	$154.20M	-155.40%	-99.90%	-115.81%	284.60%	0.48	3.07	N/A	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$165.70M	-15.60%	-13.30%	-15.12%	-44.50%	0.17	7.03	40.40%	-47.90%	-46.05%
ELDN	ELEDON PHARMACEUTICALS INC	$105.48M	-94.90%	-49.30%	-65.03%	-56.80%	1.10	6.74	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$62.02M	-153.50%	-125.50%	-184.94%	-8,454.30%	0.31	4.60	N/A	N/A	N/A
CYBN	CYBIN INC	$136.59M	-51.80%	-44.00%	-59.24%	-307.40%	0.30	8.58	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$984.11M	-53.60%	-40.80%	-55.44%	-52.30%	0.40	5.35	100.00%	-292.50%	-291.58%
RCEL	AVITA MEDICAL INC	$114.35M	N/A	-71.60%	-2,290.88%	-85.20%	-10.56	0.67	83.70%	-67.10%	-60.02%
ATOS	ATOSSA THERAPEUTICS INC	$103.34M	-49.40%	-44.80%	-60.62%	5,857.40%	0.17	6.77	N/A	N/A	N/A
CING	CINGULATE INC	$23.58M	-394.50%	-172.00%	-475.88%	-694.30%	2.03	1.26	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$104.21M	N/A	-1,545.90%	-1,556.28%	-10,196.70%	-1.08	9.16	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.81B	-50.90%	-42.70%	-51.39%	-43.50%	0.30	12.21	N/A	N/A	N/A
QSI	QUANTUM-SI INC	$295.22M	-50.90%	-45.20%	-49.07%	-54.50%	0.11	10.75	51.70%	-3,678.00%	-3,675.98%
DNA	GINKGO BIOWORKS HOLDINGS INC	$486.54M	-53.60%	-26.70%	-31.66%	-27.60%	1.12	4.39	72.70%	-188.00%	-188.24%
CRVO	CERVOMED INC	$71.06M	-76.80%	-68.10%	-98.36%	-106.60%	0.18	6.66	100.00%	-415.40%	-415.36%
MYO	MYOMO INC	$31.36M	-61.10%	-30.80%	-46.25%	-56.30%	1.33	2.49	66.60%	-28.90%	-27.63%
AVBP	ARRIVENT BIOPHARMA INC	$854.11M	-59.70%	-55.70%	-49.64%	-90.90%	0.07	14.90	N/A	N/A	N/A
CBUS	CIBUS INC	$66.23M	-166.90%	-34.90%	-27.31%	-31.10%	5.52	1.28	100.00%	-3,133.90%	-2,228.78%
CMPS	COMPASS PATHWAYS PLC	$499.77M	-172.50%	-87.70%	-398.09%	-1,036.90%	5.80	1.23	N/A	N/A	N/A
MGNX	MACROGENICS INC	$94.89M	-98.30%	-30.30%	-31.21%	-50.60%	3.04	5.22	75.40%	-59.50%	-55.34%
IMVT	IMMUNOVANT INC	$4.16B	-84.90%	-76.10%	-88.98%	8,805.10%	0.12	9.07	N/A	N/A	N/A
MDAI	SPECTRAL AI INC	$46.65M	N/A	-102.10%	3,348.60%	1,183.90%	-2.87	0.85	45.00%	-70.60%	-67.21%
MDCX	MEDICUS PHARMA LTD	$52.65M	-1,810.20%	-415.30%	4,357.13%	2,167.00%	-11.85	0.92	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$1.70B	-33.20%	-31.30%	-37.30%	-35.60%	0.08	13.01	100.00%	-8,635.80%	-8,635.85%
BCTX	BRIACELL THERAPEUTICS CORP	$17.27M	-293.30%	-181.80%	-150.92%	-1,982.80%	0.25	5.01	N/A	N/A	N/A
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$152.02M	-251.50%	-170.00%	-1,492.94%	4,106.10%	4.25	0.84	67.90%	-3,941.70%	-3,938.38%
LNAI	LUNAI BIOWORKS INC	$24.84M	-385.10%	-214.50%	1,021.63%	738.00%	-1.53	0.04	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$3.73M	-3,398.90%	-296.80%	2,075.55%	435.50%	-7.74	0.38	N/A	N/A	N/A
KAPA	KAIROS PHARMA LTD	$17.26M	-79.20%	-71.20%	-66.05%	-177.20%	0.05	16.56	N/A	N/A	N/A
BNBX	APPLIED DNA SCIENCES INC	$3.68M	-681.60%	-522.00%	-166.93%	-1,287.60%	0.41	2.77	39.60%	-2,047.40%	-399.87%
TECX	TECTONIC THERAPEUTIC INC	$347.00M	-27.10%	-25.90%	-24.75%	9,383.70%	0.04	29.15	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$289.30M	-91.80%	-74.60%	-92.80%	-119.70%	0.35	4.06	N/A	N/A	N/A
OSTX	OS THERAPIES INC	$63.39M	N/A	-278.90%	-380.14%	550.60%	1.17	0.56	N/A	N/A	N/A
ATYR	ATYR PHARMA INC	$73.78M	-100.10%	-74.70%	-82.58%	-88.10%	0.33	5.93	100.00%	-39,537.90%	-39,537.89%
SPRY	ARS PHARMACEUTICALS INC	$811.55M	-38.80%	-23.50%	-24.77%	-23.50%	1.53	6.66	89.40%	-56.10%	-55.86%
BIAF	BIOAFFINITY TECHNOLOGIES INC	$8.28M	-545.50%	-207.90%	-159.38%	-2,419.70%	0.30	3.65	27.90%	-217.50%	-216.06%
ETHZ	ETHZILLA CORP	$317.99M	-199.50%	-89.30%	-23.60%	-96.60%	1.27	10.07	100.00%	-5,671.90%	-5,476.00%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$222.47M	-320.10%	-106.20%	-88.59%	-154.00%	1.40	4.73	93.00%	-2,665.00%	-2,645.49%
VVOS	VIVOS THERAPEUTICS INC	$17.56M	-232.80%	-84.30%	-73.04%	-246.70%	4.68	1.05	55.90%	-99.50%	-99.49%
RXRX	RECURSION PHARMACEUTICALS INC	$2.16B	-72.70%	-52.50%	-57.51%	-311.80%	0.34	4.60	-59.00%	-1,637.80%	-1,638.15%
SKYE	SKYE BIOSCIENCE INC	$41.67M	-100.50%	-88.70%	-155.57%	-417.30%	0.26	4.77	N/A	N/A	N/A
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$1.05B	-293.90%	-59.90%	-34.20%	-117.30%	0.09	13.33	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$14.91M	N/A	-697.20%	68.47%	66.90%	-1.07	0.07	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$820.23M	-57.10%	-45.90%	-56.85%	-96.50%	0.43	8.50	N/A	N/A	N/A
AGL	AGILON HEALTH INC	$238.80M	-73.10%	-17.70%	-84.20%	-114.70%	4.22	1.08	-1.80%	-5.20%	-5.10%
LGVN	LONGEVERON INC	$14.55M	-138.40%	-108.50%	-201.01%	-1,125.00%	0.56	2.09	74.90%	-1,485.10%	-1,485.11%
ENLV	ENLIVEX THERAPEUTICS LTD	$24.07M	-62.90%	-53.30%	-82.65%	-29,748.70%	0.20	6.43	N/A	N/A	N/A
SNSE	SENSEI BIOTHERAPEUTICS INC	$10.10M	-80.00%	-67.50%	-104.06%	-104.00%	0.20	5.81	N/A	N/A	N/A
GOVX	GEOVAX LABS INC	$13.37M	-489.70%	-325.80%	-515.77%	27,088.00%	0.37	3.57	N/A	N/A	N/A
CSBR	CHAMPIONS ONCOLOGY INC	$93.76M	87.90%	9.90%	36.58%	36.90%	7.70	0.93	48.50%	5.20%	5.05%
POAS	PHAOS TECHNOLOGY (CAYMAN) HOLDINGS LTD	N/A	-1,073.10%	-144.30%	275.47%	9,727.00%	-1.99	0.40	22.10%	-3,063.10%	-3,058.07%
IBO	IMPACT BIOMEDICAL INC	$50.22M	N/A	-227.80%	771.62%	54,207.50%	-2.29	0.04	52.00%	-176,764.00%	-172,380.00%
IGC	IGC PHARMA INC	$33.43M	-96.40%	-72.60%	-78.33%	-188.00%	0.20	1.32	46.20%	-582.80%	-582.82%
SYBX	SYNLOGIC INC	$19.65M	-26.50%	-18.00%	-31.25%	63.90%	0.60	2.65	N/A	N/A	N/A
PMCB	PHARMACYTE BIOTECH INC	$5.79M	-12.50%	-11.20%	-2.55%	-3.80%	0.04	18.01	N/A	N/A	N/A
EDSA	EDESA BIOTECH INC	$12.29M	-103.10%	-78.70%	-37.56%	570.50%	0.06	15.73	N/A	N/A	N/A
ATHE	ALTERITY THERAPEUTICS LTD	$70.10M	-43.20%	-37.20%	-28.43%	-222.50%	0.09	12.98	100.00%	-159.00%	-158.08%
IMRN	IMMURON LTD	$9.24M	-50.30%	-40.70%	-63.80%	-160.50%	0.26	5.09	71.00%	-60.00%	-59.88%
EMPG	EMPRO GROUP INC	N/A	69.70%	19.70%	54.59%	42.70%	4.10	1.45	61.80%	13.70%	20.11%
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$11.39M	N/A	-2,305.80%	249.19%	1,368.80%	-1.21	0.17	45.50%	-1,635,199.10%	-1,470,928.44%
RADX	RADIOPHARM THERANOSTICS LTD	$35.45M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
DYAI	DYADIC INTERNATIONAL INC	$33.00M	-537.20%	-78.10%	-90.29%	-119.30%	3.48	2.85	31.50%	-219.90%	-205.87%
VYNE	VYNE THERAPEUTICS INC	$12.36M	-80.60%	-66.00%	-104.91%	-173.00%	0.13	8.87	100.00%	-6,425.20%	-6,424.43%
XBIO	XENETIC BIOSCIENCES INC	$5.96M	-64.60%	-54.60%	-79.78%	1,819.80%	0.28	4.56	100.00%	-110.40%	-110.40%
CTSO	CYTOSORBENTS CORP	$41.45M	-91.50%	-22.10%	-28.58%	-19.00%	4.07	2.11	77.00%	-30.80%	-29.65%
XBIT	XBIOTECH INC	$80.49M	-16.70%	-15.90%	-17.02%	-134.50%	0.03	41.78	N/A	N/A	N/A
VTAK	CATHETER PRECISION INC	$3.24M	-267.00%	-85.70%	-75.63%	3,769.40%	2.81	0.46	92.60%	-3,039.90%	-2,087.40%
AVDL	AVADEL PHARMACEUTICALS PLC	$2.30B	-0.30%	-0.20%	4.71%	7.80%	1.03	2.76	94.90%	-0.10%	2.60%
SGMO	SANGAMO THERAPEUTICS INC	$149.74M	-814.00%	-116.50%	-283.90%	-311.60%	13.20	0.88	100.00%	-331.30%	-332.63%
XCUR	EXICURE INC	$27.09M	-108.80%	-52.90%	-73.84%	-897.50%	1.20	1.96	N/A	N/A	N/A
TVGN	TEVOGEN BIO HOLDINGS INC	$82.85M	N/A	-771.10%	1,393.99%	-8,185.70%	-1.57	0.32	N/A	N/A	N/A
INAB	IN8BIO INC	$7.37M	-145.50%	-107.40%	-137.13%	-231.40%	0.27	6.91	N/A	N/A	N/A
STAA	STAAR SURGICAL CO	$1.31B	-26.80%	-20.70%	-23.29%	-33.80%	0.29	5.21	73.90%	-41.80%	-39.87%
ADXN	ADDEX THERAPEUTICS LTD	$6.66M	-66.80%	-59.30%	-82.04%	-95.50%	0.18	2.31	100.00%	-3,616.40%	-3,607.23%
TCRT	ALAUNOS THERAPEUTICS INC	$5.49M	-168.00%	-120.70%	-143.60%	-479.50%	0.33	2.92	100.00%	-100,625.00%	-100,625.00%
ANEB	ANEBULO PHARMACEUTICALS INC	$93.67M	-67.80%	-64.10%	-83.21%	7,349.80%	0.10	10.93	N/A	N/A	N/A
CUE	CUE BIOPHARMA INC	$49.60M	-271.70%	-118.90%	-231.28%	-1,177.90%	1.39	1.66	100.00%	-530.70%	-525.10%
AKTX	AKARI THERAPEUTICS PLC	$37.81M	-68.40%	-31.90%	-55.39%	105.10%	1.00	0.19	N/A	N/A	N/A
DRMA	DERMATA THERAPEUTICS INC	$3.15M	-192.00%	-140.20%	N/A	-2,889.20%	0.28	N/A	N/A	N/A	N/A
LPCN	LIPOCINE INC	$15.93M	-30.60%	-28.20%	-38.71%	-42.10%	0.14	8.25	100.00%	-126.70%	-126.66%
ZYXI	ZYNEX INC	$17.27M	-122.60%	-26.10%	-166.79%	-21.40%	67.15	0.62	75.40%	-19.80%	-13.91%
SRZN	SURROZEN INC	$111.26M	-5,313.30%	-116.50%	-119.80%	-835.10%	-5.00	13.15	100.00%	-6,400.70%	-6,400.73%
PLUR	PLURI INC	$35.72M	N/A	-64.10%	-1,420.17%	-55.20%	-2.64	0.53	42.90%	-1,700.70%	-1,619.38%
CCM	CONCORD MEDICAL SERVICES HOLDINGS LTD	$20.11M	N/A	-0.10%	6.46%	3.90%	-2.24	0.42	144.20%	-1.10%	47.29%
TELA	TELA BIO INC	$40.30M	-272.10%	-53.20%	-76.59%	-61.40%	38.56	3.30	67.20%	-50.60%	-44.34%
LFWD	LIFEWARD LTD	$10.60M	-183.20%	-109.30%	-211.12%	-431.10%	0.82	1.92	37.50%	-121.80%	-121.64%
PINC	PREMIER INC	$2.33B	-2.10%	-1.10%	-0.34%	-0.40%	1.00	0.62	73.00%	-3.30%	-0.75%
CLSD	CLEARSIDE BIOMEDICAL INC	$19.99M	N/A	-144.90%	-284.98%	-43.80%	-1.22	2.98	-29.70%	-8,495.40%	-8,261.76%
NVNO	ENVVENO MEDICAL CORP	$8.49M	-61.50%	-56.90%	-73.33%	-62.40%	0.10	13.13	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$84.29M	N/A	N/A	N/A	N/A	-1.55	1.89	N/A	N/A	N/A
ANL	ADLAI NORTYE LTD	$57.51M	-98.90%	-51.50%	-192.69%	-828.00%	1.80	1.41	N/A	N/A	N/A
APLM	APOLLOMICS INC	$27.08M	-233.70%	-157.30%	-937.36%	2,070.90%	1.69	1.39	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	622	+2.21%	+5.88%	+6.40%	-48.25%	281.87x	5.09x	-29.02%	-10.16%	-18.75%	+51.64%	Strong Buy
Diagnostics & Research	57	-0.54%	-0.05%	+7.81%	+13.10%	24.30x	4.32x	-0.70%	+6.66%	+14.00%	+6.65%	Strong Buy
Drug Manufacturers - General	20	+0.07%	+7.27%	+13.49%	+21.54%	46.21x	6.69x	+109.29%	+12.14%	+20.22%	+1.52%	Hold
Drug Manufacturers - Specialty & Generic	77	+0.23%	+0.36%	-1.67%	-13.53%	25.64x	2.17x	+10.81%	+3.81%	+7.20%	+39.58%	Strong Buy
Healthcare Plans	10	-1.12%	-1.70%	-11.49%	-30.09%	43.50x	1.99x	+12.29%	+3.80%	+9.27%	+22.65%	Buy
Health Information Services	55	-0.49%	-3.70%	-3.58%	-54.29%	41.04x	4.01x	+7.75%	+4.89%	+7.18%	+35.49%	Strong Buy
Medical Care Facilities	48	-0.85%	-1.86%	+0.24%	-21.33%	14.89x	5.29x	-83.73%	+7.67%	+16.73%	+20.32%	Buy
Medical Devices	138	-0.59%	+2.09%	+2.40%	-33.58%	26.64x	3.95x	+12.07%	+7.32%	+8.25%	+25.76%	Strong Buy
Medical Distribution	11	-0.70%	-0.56%	+11.83%	+39.03%	30.11x	433.03x	-34.73%	+3.63%	+22.01%	+4.72%	Buy
Medical Instruments & Supplies	56	-1.36%	-0.06%	+3.18%	-38.36%	198.44x	3.63x	+10.81%	+8.87%	+11.84%	+19.69%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1094 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 39, which is 13 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Pediatrix Medical Group has seen its stock return 56.84% over the past year, overperforming other healthcare stocks by 89 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -7.85% from Pediatrix Medical Group's current stock price of $23.15.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #2 top healthcare stock out of 1094 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 51.9% over the past year, overperforming other healthcare stocks by 84 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $46.67, an upside of 1.49% from Collegium Pharmaceutical's current stock price of $45.98.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Collegium Pharmaceutical, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top healthcare stock out of 1094 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 27, which is 1 points higher than the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 200.39% over the past year, overperforming other healthcare stocks by 232 percentage points.

Indivior has an average 1 year price target of $32.50, an upside of 6.59% from Indivior's current stock price of $30.49.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.57%, which is 11 percentage points higher than the healthcare sector average of 2.07%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 36% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.84%, which is 9 percentage points higher than the healthcare sector average of 2.07%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.99%, which is 7 percentage points higher than the healthcare sector average of 2.07%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.35% in the last day, and up 2.34% over the last week. Cypherpunk Technologies was the among the top gainers in the healthcare sector, gaining 368.04% yesterday.

Leap Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.12% in the past year. It has overperformed other stocks in the healthcare sector by 35 percentage points.

2. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -50.82% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -28.31% in the past year. It has overperformed other stocks in the healthcare sector by 4 percentage points.

Are healthcare stocks a good buy now?

54.43% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 28.61% over the next year.

8.08% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.89% of healthcare stocks are rated B (Buy), 46.72% are rated C (Hold), 24.47% are rated D (Sell), and 9.84% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 84.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.